Delphinus Medical Technologies Lands $8,000,000 New Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d36f757f-bfa0-4c2c-9a39-d103d82a5103&Preview=1 -
Date
5/25/2010 -
Company Name
Delphinus Medical Technologies -
Mailing Address
Hudson-Webber Cancer Research Center Detroit, MI 48201 -
Company Description
Delphinus Medical Technologies, LLC., is a Michigan company and a spin-off of the Barbara Ann Karmanos Cancer Institute (KCI). Delphinus has succeeded in building a three-dimensional full-breast ultrasound imaging device that effectively differentiates benign from malignant masses in breast cancer cases using a safe (non-ionizing), comfortable (non-compressing), and reliable (operator independent) patented technology. Utilizing multi-parametric ultrasound and sophisticated computer algorithms, rather than X-rays, SoftVue safely and comfortably screens women for breast cancer, assesses breast cancer risk, diagnoses breast diseases and monitors therapy. -
Website
http://www.delphinusmt.com/
-
Transaction Type
Venture Equity -
Transaction Amount
$8,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
This research will further validate the initial findings in order to obtain approval from the U.S. Food and Drug Administration. -
M&A Terms
-
Venture Investor
Arboretum Ventures -
Venture Investor
Beringea -
Venture Investor
Undisclosed
